Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.37 |
| ▸ | GABRD | O14764 | 2/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.37 |
| ▸ | GABRE | P78334 | 2/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.37 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.37 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.37 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.37 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.37 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2722759 | 0.80 | GRIK1 (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2725486 | 0.80 | GRIK1 (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL27608538 | 0.80 | CA2 (0.32) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2722763 | 0.80 | GRIK1 (0.39) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL23829579 | 0.79 | ALDH1A1 (0.50) | TDP1 | |
| SCHEMBL5689593 | 0.79 | SLC22A6 (0.39) | SLC22A6TDP1GABRPGABRDGABRA1 | |
| SCHEMBL7354948 | 0.79 | SLC22A6 (0.39) | SLC22A6TDP1GABRPGABRDGABRA1 | |
| SCHEMBL17337272 | 0.77 | GABRP (0.41) | SLC22A6TDP1GABRPGABRDGABRA1 | |
| Sulfuric Acid SCHEMBL75927 | 0.77 | GABRP (0.46) | SLC22A6TDP1GABRPGABRDGABRA1 | |
| Sulfuric Acid SCHEMBL6854842 | 0.77 | GABRP (0.46) | SLC22A6TDP1GABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004076400-A1 | ANTIMICROBIAL AGENT AGAINST BACTERIA, YEAST AND MOULDS | DR. RIEKS GMBH (DE) | 2004-09-10 | — | — | WO | claimed |
| US-20220175808-A1 | GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS | GLYCOMIMETICS, INC. (US) | 2022-06-09 | — | — | US | disclosed |
| US-11197877-B2 | Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists | GLYCOMIMETICS. INC. (US) | 2021-12-14 | — | — | US | disclosed |
| US-20200129536-A1 | GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS | GLYCOMIMETICS, INC. (US) | 2020-04-30 | — | — | US | disclosed |
| US-9482955-B2 | Lithographic printing plate precursor and plate making method thereof | FUJIFILM CORPORATION (JP) | 2016-11-01 | — | — | US | disclosed |
| US-20140329746-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2014-11-06 | — | — | US | disclosed |
| US-8835654-B2 | Method and compositions for treating amyloid-related diseases | BHI LIMITED PARTNERSHIP (CA) | 2014-09-16 | — | — | US | disclosed |
| US-20140107027-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | BHI LIMITED PARTNERSHIP (CA) | 2014-04-17 | — | — | US | disclosed |
| US-20140080054-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD THEREOF | FUJIFILM CORPORATION (JP) | 2014-03-20 | — | — | US | disclosed |
| US-8142982-B2 | Lithographic printing plate precursor | FUJIFILM CORPORATION (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20120015911-A1 | METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | BELLUS HEALTH INC. (CA) | 2012-01-19 | — | — | US | disclosed |
| US-7572459-B2 | Prevention infections in humans, animals | STARPHARMA PTY LTD. (AU) | 2009-08-11 | — | — | US | disclosed |
| US-20090111049-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2009-04-30 | — | — | US | disclosed |
| WO-2005012210-A2 | ANTIMICROBIAL ACTIVE PREPARATIONS CONTAINING TERPENE DERIVATIVES | DR. ANDRE RIEKS - LABOR FÜR ENZYMTECHNOLOGIE GMBH (DE) | 2005-02-10 | — | — | WO | disclosed |
| WO-2004076400-A1 | ANTIMICROBIAL AGENT AGAINST BACTERIA, YEAST AND MOULDS | DR. RIEKS GMBH (DE) | 2004-09-10 | — | — | WO | disclosed |
| WO-1994004555-A1 | ANTI-ANDROGENE STEROIDS WITH AN ANNULATED FIVE-MEMBERED RING | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-03-03 | — | — | WO | disclosed |
| CN-1041592-A | Sultamsulfonamide derivatives and weedicide | NISSAN CHEMICAL IND LTD (JP) | 1990-04-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175808-A1 | GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS | SELE, SELPLG, SELP | SLC22A6 929/4885TDP1 3520/4885GABRP 807/4885 |
| US-11197877-B2 | Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists | SELE, SELPLG, SELP | SLC22A6 959/4885TDP1 2966/4885GABRP 1129/4885 |
| US-20140329746-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | APP, PSEN1, PSEN2 | SLC22A6 1256/4885TDP1 650/4885GABRP 3088/4885 |
| US-20140107027-A1 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | APP, PSEN1, PSEN2 | SLC22A6 1256/4885TDP1 650/4885GABRP 3088/4885 |
| US-20120015911-A1 | METHOD AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | APP, PSEN1, PSEN2 | SLC22A6 1281/4885TDP1 793/4885GABRP 3013/4885 |
| US-20200129536-A1 | GALACTOPYRANOSYL-CYCLOHEXYL DERIVATIVES AS E-SELECTIN ANTAGONISTS | SELE, SELPLG, SELP | SLC22A6 929/4885TDP1 3520/4885GABRP 807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.